Agilent Prices Public Offering of Senior Notes at $400M | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday.

The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

The Santa Clara, Calif.-based company announced the offering earlier on Monday but did not price it. Following the announcement, ratings agencies Moody's and Fitch issued ratings on the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.